$82.5 Million
Milestone Pharmaceuticals Inc.
Initial Public Offering
Active Bookrunner
$165.6 Million
Pliant Therapeutics, Inc.
Initial Public Offering
Active Bookrunner
$604.4 Million
Moderna Therapeutics, Inc.
Initial Public Offering
Passive Bookrunner
$120.0 Million
Arvinas
Initial Public Offering
Active Bookrunner
$117.3 Million
Crinetics Pharmaceuticals, Inc.
Initial Public Offering
Active Bookrunner
$138.0 Million
OptiNose AS
Initial Public Offering
Active Bookrunner
$136.9 Million
Menlo Therapeutics Inc.
Initial Public Offering
Active Bookrunner
$46.0 Million
Arsanis Inc.
Initial Public Offering
Passive Bookrunner
$138.8 Million
Deciphera Pharmaceuticals, Inc.
Initial Public Offering
Active Bookrunner
$42.2 Million
ASLAN Pharmaceuticals Pte. Ltd.
Initial Public Offering
Active Bookrunner
Subscribe to Biopharma

© 2025 Piper Sandler Companies. Since 1895. All rights reserved.